Showing material events only. Routine administrative filings — bylaw amendments, technical fund updates, procedural FD disclosures — are filtered out so the front page stays signal-dense.
6-K
Operational Other
confidence 85%
filed 2026-09-28
EX-99.1
The press release announces a strategic cooperation agreement between Lianhe Sowell and Kumquat Technology (a Chery Group subsidiary) to develop and promote intelligent equipment solutions across China's automotive aftermarket. This is a material operational and commercial partnership involving product collaboration, market development, and distribution through Chery's 1,000 4S store network, but it does not constitute a merger, acquisition, or change of control (ma_activity), nor does it fit other specific event categories. The agreement represents a significant business development opportunity for the company's core industrial automation products.
View raw filing on EDGAR →
8-K
Material Litigation
confidence 95%
filed 2026-09-28
A securities class action lawsuit was filed on September 3, 2026 in the U.S. District Court for the Northern District of California against Unicycive Therapeutics and certain officers, alleging violations of federal securities laws related to public statements about the company's new drug application for oxylanthanum carbonate phosphate binder. This is a material securities litigation disclosure that would affect a reasonable investor's assessment of the registrant's legal and financial exposure.
View raw filing on EDGAR →
8-K
Dilutive issuance
confidence 95%
filed 2026-09-28
Item 1.01
The Company entered into a securities purchase agreement to sell 1,320,000 shares of common stock in a direct registered offering to institutional investors, generating approximately $17.2 million in net proceeds. This is a material dilutive equity issuance to raise capital for mining operations and working capital, filed under Item 1.01 as a material definitive agreement. The disclosure also notes termination of a prior ATM program, further confirming the capital-raising nature of this transaction.
View raw filing on EDGAR →
8-K
Exec departure
confidence 75%
filed 2026-09-28
Item 5.02
Herb Cross resigned as Chief Financial Officer, Principal Financial Officer, Principal Accounting Officer and Corporate Secretary effective October 9, 2026. While the filing also discloses interim appointments to fill these roles, the principal disclosed action is the departure of a named executive officer holding critical financial and governance positions. The departure of a CFO is material to investors assessing the registrant's financial leadership and continuity.
View raw filing on EDGAR →
8-K
M&A activity
confidence 95%
filed 2026-09-28
Item 7.01
The filing discloses the completion of a business combination between Viking Acquisition Corp. I (a SPAC) and NorthStar Earth & Space Inc., expected to close on September 30, 2026. The press release announces the transaction closing, the resulting company name change to NorthStar Earth & Space Enterprises, Inc., and the transfer of listing to NYSE American with new trading symbols. This is a material acquisition/change of control event that would significantly affect investor assessment of the registrant.
View raw filing on EDGAR →
8-K
M&A activity
confidence 95%
filed 2026-09-28
Item 8.01
The filing discloses entry into a non-binding term sheet for the sale of Faraday Future's robotics business to AIxCrypto Holdings, Inc. for a proposed $200 million purchase price payable in equity. Although non-binding, this represents a material acquisition/disposition activity involving a significant business unit, approved by the Board and Special Committee, with expected closing in Q4 2026. This falls squarely within Item 1.01/2.01 M&A activity disclosure requirements.
View raw filing on EDGAR →
8-K
Shareholder vote
confidence 95%
filed 2026-09-28
Item 5.07
This Item 5.07 discloses the results of Lakewood-Amedex's 2026 Annual Meeting of Stockholders held on September 22, 2026, including voting outcomes on five proposals: election of four directors, amendment to increase authorized shares from 12.5M to 100M, authorization for a reverse stock split up to 1:20, amendment to the 2020 Equity Incentive Plan to increase shares to 400,000, and ratification of CBIZ CPAs P.C. as independent auditor. All proposals passed with substantial majorities. The authorization for a reverse stock split and increase in authorized shares are particularly material to investors assessing potential dilution and capital structure changes.
View raw filing on EDGAR →
8-K
Exec departure
confidence 95%
filed 2026-09-28
Item 5.02
George Kollitides, an independent director, resigned from the Board effective immediately on September 23, 2026. The filing discloses a departure of a director from the Company's Board, which is material to investors as it affects board composition and governance. The explicit statement that the resignation was not related to disagreement with the Company does not diminish the materiality of the director departure itself.
View raw filing on EDGAR →
8-K
M&A activity
confidence 95%
filed 2026-09-28
The filing discloses a proposed merger between VerifyMe, Inc. and Open World Ltd., with stockholder approval obtained on September 24, 2026. The 8-K provides pro forma financial information and audited/unaudited financial statements of the target (OpenWorld) as required by Nasdaq for merger disclosure. The checkbox for "Written communications pursuant to Rule 425" is marked, confirming this is merger-related disclosure under securities law. This is a material acquisition/change of control event.
View raw filing on EDGAR →
8-K
M&A activity
confidence 98%
filed 2026-09-28
Item 8.01
TransDigm announced the completion of its acquisition of Prince & Izant for approximately $1.066 billion in cash on September 28, 2026. The filing explicitly states "the completion of the acquisition" and provides detailed information about the acquired company's business, revenue (~$390 million), and operations. This is a material acquisition completion that would significantly affect investor assessment of TransDigm's capital deployment and strategic positioning.
View raw filing on EDGAR →
6-K
Operational Other
confidence 72%
filed 2026-09-28
EX-99.1
This exhibit is a press release announcing Sigma Lithium's recognition at UN-Climate Week for sustainability and cleantech innovation in lithium oxide industrialization, combined with an operational update addressing recent legal challenges in Brazil. The primary disclosure is operational and strategic (company recognition, production capacity, job creation), but the material substance lies in the company's response to unspecified "ongoing legal reviews" affecting its mining concessions and environmental licenses. The company states operations "continue normally" and mining rights are "not affected," but the defensive tone and references to Federal Courts reviewing appeals and District Attorneys' filings suggest material legal/regulatory uncertainty that could affect operations. This does not fit neatly into a single category—it is neither a discrete legal event (no specific litigation or covenant breach disclosed) nor purely operational, but rather a mixed operational-legal disclosure addressing regulatory risk.
View raw filing on EDGAR →
8-K
Operational Other
confidence 85%
filed 2026-09-28
Item 8.01
CapsoVision announced FDA clearance of AI Highlights™, an AI-assisted reading feature for its CapsoCam Plus® system, received on September 25, 2026. This is a material regulatory milestone for a commercial-stage medical technology company—FDA clearance of a new product feature expands the company's commercial capabilities and competitive positioning in the capsule endoscopy market. While not a specific named event type, this is clearly an operational/strategic milestone (regulatory approval enabling product commercialization) rather than a financial, governance, or legal event, making operational_other the most appropriate classification.
View raw filing on EDGAR →
8-K
Exec departure
confidence 95%
filed 2026-09-28
Item 5.02
Donna A. Henderson, Vice President and Chief Accounting Officer of Archrock, Inc., notified the Company on September 23, 2026 of her intention to retire effective December 4, 2026. This is a clear departure of a named executive officer responsible for accounting functions, which is material to investors' assessment of the company's financial reporting and internal controls.
View raw filing on EDGAR →
8-K
Debt Issuance
confidence 75%
filed 2026-09-28
Item 1.01
The filing discloses amendments to two material receivables purchase agreements (dated September 28, 2022 and March 1, 2023) that extend the termination dates of financing facilities from January 31, 2028 to January 31, 2030. While these are amendments to existing credit facilities rather than new debt issuances, they represent material modifications to the Company's direct financial obligations and credit arrangements. The extension of facility termination dates is a significant refinancing event affecting the Company's capital structure and liquidity profile.
View raw filing on EDGAR →
8-K
Financial Other
confidence 75%
filed 2026-09-28
Item 8.01
The disclosure describes completion of a material divestiture transaction involving the redemption of equity interests in Chobani for $800 million (cash and promissory note) and sale of leasehold assets for $125 million. While this is a significant financial event involving asset disposition and capital receipt, it does not fit the specific categories of ma_activity (which typically involves acquisitions, mergers, or changes of control rather than equity redemptions), debt_issuance (the promissory note is received, not issued by KDP), or dividend_distribution. The transaction is material to investors as it represents a substantial capital event and reduction of the Company's investment portfolio.
View raw filing on EDGAR →
8-K
Dividend Distribution
confidence 92%
filed 2026-09-28
Item 8.01
PCB Bancorp's Board approved a share repurchase program authorizing the repurchase of up to 700,000 shares of common stock through September 22, 2027, representing a significant capital return to shareholders.
View raw filing on EDGAR →
8-K
Earnings release
confidence 92%
filed 2026-09-28
Item 2.02
Gray Media issued a press release on September 28, 2026, announcing updated financial guidance for Q3 2026, raising political advertising guidance from $165–$185 million to $188–$195 million and lifting the low end of total revenue guidance to $950–$965 million. While technically a guidance update rather than final results, this disclosure under Item 2.02 is a material update to forward-looking financial expectations that would affect investor assessment of the company's near-term performance and is presented in the form of a press release furnished as an exhibit, consistent with earnings-related disclosures.
View raw filing on EDGAR →
8-K
Operational Other
confidence 75%
filed 2026-09-28
Item 7.01
This disclosure announces the publication of a peer-reviewed cardiac safety analysis of Annamycin in a medical journal, demonstrating favorable safety findings across five clinical trials. While the filing is made under Item 7.01 (Regulation FD Disclosure) rather than a dedicated 8-K item, the announcement of positive clinical trial results for a lead drug candidate represents a material operational/clinical milestone that would affect investor assessment of the company's development progress and product viability. This is not a traditional earnings release, but rather a clinical validation event for an early-stage biotech company's pipeline asset.
View raw filing on EDGAR →
8-K
Operational Other
confidence 85%
filed 2026-09-28
Item 8.01
Eton Pharmaceuticals announced the commercial launch of IMPAVIDO® (miltefosine) capsules with exclusive U.S. commercialization rights and integrated patient support programs. This is a material operational and commercial milestone for a rare disease pharmaceutical company—the launch of a marketed product with full commercial infrastructure represents a significant business event, though it does not fit the specific categories of M&A, earnings, or other defined event types. The disclosure emphasizes the company's rare disease focus and the integration of patient support services, making this a material operational event.
View raw filing on EDGAR →
8-K
Exec appointment
confidence 85%
filed 2026-09-28
Item 5.02
The filing discloses two events: Ruth S. Kimmelshue's resignation as a director effective immediately, and R. Jeffrey Bailly's election to the Board as a Class I director effective September 23, 2026. While both a departure and an appointment occur, the principal disclosed action centers on Bailly's appointment, which is emphasized throughout the filing and press release as bringing "highly relevant operating and leadership experience" and "valuable expertise in medical technologies" to support the Company's strategic repositioning. The appointment is material to investors as it reflects a deliberate Board composition change aligned with the Company's strategic priorities.
View raw filing on EDGAR →
8-K
Exec Compensation
confidence 95%
filed 2026-09-28
Item 5.02
The Compensation Committee approved an increase in annual base salary for Mark A. Esquivel, President and COO, from $270,000 to $400,000 (a 48% increase effective September 28, 2026). This is a direct disclosure of a compensatory arrangement modification for a named executive officer, fitting the exec_compensation category. The material salary increase would affect investor assessment of executive compensation costs and governance decisions.
View raw filing on EDGAR →
8-K
Exec appointment
confidence 95%
filed 2026-09-28
Item 5.02
The filing discloses the appointment of Joan A. Binstock to the Board of Directors and Audit Committee of WGC USA Asset Management Company, LLC (the Sponsor of World Gold Trust) effective September 28, 2026. The principal action is a person taking a governance role, with detailed biographical information provided. Board appointments are material governance events affecting the registrant's leadership structure.
View raw filing on EDGAR →
8-K
Exec appointment
confidence 95%
filed 2026-09-28
Item 5.02
The filing discloses the appointment of Joan A. Binstock to the Board of Directors and Audit Committee of World Gold Trust Services, LLC (the Sponsor of SPDR Gold Trust) effective September 28, 2026. This is a clear executive appointment event under Item 5.02, with detailed biographical information provided for the newly appointed director, including her extensive experience in finance, audit, and governance roles at major financial institutions.
View raw filing on EDGAR →
8-K
Shareholder vote
confidence 95%
filed 2026-09-28
Item 5.07
This Item 5.07 disclosure reports the results of Friedman Industries' Annual Meeting of Shareholders held on September 22, 2026, including voting outcomes on director elections (all six nominees elected), a non-binding advisory vote on executive compensation (approved with 4,034,540 shares for), ratification of Baker Tilly US, LLP as independent auditor (approved with 5,946,451 shares for), and a failed amendment to the Articles of Incorporation regarding shareholder bylaw amendment rights (rejected with insufficient affirmative votes). The disclosure is material as it documents shareholder governance decisions and approval of executive compensation and auditor selection.
View raw filing on EDGAR →
8-K
Exec appointment
confidence 95%
filed 2026-09-28
Item 5.02
Jerry Stumbo was appointed as Executive Vice President – Refining and Logistics, effective September 28, 2026, succeeding Richard Creamer who will retire effective April 1, 2027. This represents a material leadership transition in a key operational function at the energy company.
View raw filing on EDGAR →
8-K
Shareholder vote
confidence 95%
filed 2026-09-28
Item 5.07
Stockholders voted at the Annual Meeting of Stockholders on three proposals: election of six directors, ratification of Grant Thornton, LLP as independent auditor, and approval of an amendment to the 2020 Long Term Incentive Plan increasing the share reserve by 1,500,000 shares. Detailed voting results for each proposal and director nominee were disclosed.
View raw filing on EDGAR →
8-K
Shareholder vote
confidence 98%
filed 2026-09-28
Item 5.07
This is a clear disclosure of shareholder voting results from ParkerVision's Annual Meeting of Shareholders held on September 25, 2026. The filing reports final voting tallies for two proposals: election of Class I and Class II directors (Jeffrey L. Parker and Anthony B. Bowers) and ratification of Frazier & Deeter, LLC as independent auditor. This is the quintessential Item 5.07 disclosure and is material to investors as it confirms governance outcomes and auditor selection.
View raw filing on EDGAR →
8-K
Debt Issuance
confidence 94%
filed 2026-09-28
Item 1.01
Vinebrook Homes Trust entered into a $25.0 million credit agreement with The Ohio State Life Insurance Company on September 28, 2026, with $4.0 million funded immediately and $21.0 million to be funded by October 2, 2026. The debt bears 10.0% interest, matures September 28, 2027, and is secured by pledges of membership interests and real property proceeds.
View raw filing on EDGAR →
8-K
Dilutive issuance
confidence 92%
filed 2026-09-28
Item 1.01
AZIO AI Holdings entered into a Standby Equity Purchase Agreement (SEPA) with YA II PN, Ltd. providing for up to $50 million in equity financing through convertible promissory notes ($3.5 million pre-paid advance), warrants for 1,735,758 shares at $0.01 exercise price, and commitment to purchase up to $50 million of common stock, contemplating issuance of up to 28 million shares subject to a 19.99% Exchange Cap. The unregistered securities were issued in reliance on Section 4(a)(2) exemption, representing a significant dilutive private placement.
View raw filing on EDGAR →
8-K
Earnings release
confidence 98%
filed 2026-09-28
Item 2.02
IDT Corporation issued a press release on September 28, 2026, announcing its results of operations for the fiscal quarter and fiscal year ended July 31, 2026. The filing discloses consolidated financial results including revenue (+7% to $339.0M in 4Q26, +5% to $1,298.0M in FY26), gross profit, income from operations (+52% in 4Q26, +21% in FY26), net income, EPS, and Adjusted EBITDA (+22% in 4Q26, +17% in FY26), along with detailed segment performance. This is a standard earnings release disclosure under Item 2.02, furnished as Exhibit 99.1.
View raw filing on EDGAR →
8-K
Operational Other
confidence 75%
filed 2026-09-28
Item 7.01
CervoMed announced pharmacokinetic, regulatory, and manufacturing advances for its lead drug candidate neflamapimod, including a new 50 mg tablet formulation with improved PK profile, FDA removal of a prior drug exposure limit, and a controlled manufacturing process that enable advancement of a higher-dose 100 mg twice-daily regimen in future clinical trials.
View raw filing on EDGAR →
8-K
Operational Other
confidence 75%
filed 2026-09-28
Item 8.01
Coastal Financial discloses that Bluevine, Inc., a long-standing fintech partner, has entered into a definitive agreement to be acquired by Valley National Bancorp. While the company states it does not expect a material adverse effect on liquidity or funding, the disclosure of approximately $447 million in Bluevine-related deposits on the balance sheet as of September 25, 2026, and the potential for changes to this relationship following the transaction, represents a material operational and strategic event affecting the company's deposit funding profile and partner ecosystem. This is a significant third-party transaction affecting a material business relationship rather than a direct M&A activity by Coastal itself.
View raw filing on EDGAR →
8-K
Governance Other
confidence 75%
filed 2026-09-28
Item 8.01
The disclosure centers on the Audit Committee's discovery of a previously undisclosed Executive Employment Agreement with Allison Dewan (daughter of CEO Derek Dewan), raising governance and disclosure control concerns. While the agreement itself involves executive compensation, the material event is the governance failure—the non-disclosure of a related-party employment arrangement and the Audit Committee's investigation into whether it should have been disclosed as a related-party transaction and whether disclosure controls failed. This is a governance/internal control matter rather than a routine compensation arrangement.
View raw filing on EDGAR →
6-K
Delisting risk
confidence 92%
filed 2026-09-28
EX-99.1
The press release announces that Orion Digital has regained compliance with Nasdaq's minimum bid price requirement (Nasdaq Listing Rule 5550(a)(2)) after the stock price fell below US$1.00. This disclosure directly addresses a delisting risk — the Company was previously out of compliance with a continued listing standard and has now cured that deficiency. The announcement of regaining compliance is material because it resolves an existential threat to the Company's exchange listing.
View raw filing on EDGAR →
6-K
Delisting risk
confidence 95%
filed 2026-09-28
EX-99.1
The exhibit announces that the Nasdaq Hearings Panel has denied the Company's request to reinstate trading and determined to delist the Company's securities effective September 23, 2026. The Panel's decision was based on trading activity indicative of potential manipulation and insufficient liquidity. This is a definitive delisting determination (not merely a risk or notice of non-compliance), making it a material event that directly affects the registrant's continued listing status and investor access to the securities.
View raw filing on EDGAR →
8-K
Debt Issuance
confidence 85%
filed 2026-09-28
The filing discloses entry into a Securities Purchase Agreement on September 23, 2026, for up to $25.0 million of senior secured convertible promissory notes with warrants, with an initial closing of $11.01 million completed on September 24, 2026. This represents creation of a new direct financial obligation (Item 1.01), which is the primary material event disclosed. While the notes are convertible (creating dilution potential), the core transaction is debt issuance with security interests and board rights attached.
View raw filing on EDGAR →
8-K
Auditor Change
confidence 98%
filed 2026-09-28
Item 4.01
The filing discloses the dismissal of Grassi & Co., CPAs, P.C. as the Company's independent registered public accounting firm and the engagement of Rosenberg Rich Baker Berman P.A. as the new auditor, effective September 22, 2026. This is a classic auditor change under Item 4.01. While the prior auditor's reports contained an explanatory paragraph noting substantial doubt about going concern, the core event disclosed is the change in auditors itself, which is material to investors' assessment of financial reporting oversight.
View raw filing on EDGAR →
8-K
Operational Other
confidence 75%
filed 2026-09-28
Soluna announced an amended agreement with Bitdeer to expand Bitcoin mining deployment at Project Kati 1 from 28 MW to 35 MW (adding ~7 MW), bringing hash rate to approximately 2.42 EH/s. This is a material operational and strategic expansion of an existing partnership involving significant capital deployment and revenue-generating capacity, but it does not constitute a new M&A transaction, debt issuance, or other specifically-named event type. The co-mining arrangement structure and expansion of computing infrastructure capacity is a material operational milestone for the company's core business.
View raw filing on EDGAR →
8-K
Governance Other
confidence 85%
filed 2026-09-28
The filing discloses a one-for-fifteen reverse stock split of Matinas BioPharma's common stock, effective September 28, 2026, pursuant to a Certificate of Amendment filed with Delaware and previously approved by stockholders on June 23, 2025. While a reverse stock split is a capital structure modification affecting all shareholders uniformly, it is a governance matter (amendment to articles of incorporation) rather than a specific named event type. The reverse split is material to investors as it affects share count, trading price, and the terms of all outstanding securities including options and warrants.
View raw filing on EDGAR →
6-K
M&A activity
confidence 98%
filed 2026-09-28
EX-99.1
The exhibit announces the completion of LogProstyle's acquisition of 100% of I-FLATZ Corporation's outstanding shares on September 28, 2026, first disclosed on August 27, 2026. The transaction expands the company's geographic footprint from Tokyo into the Kansai region and is explicitly characterized as "an important milestone in our strategy." This is a material acquisition event that would affect a reasonable investor's assessment of the registrant's business scope and growth trajectory.
View raw filing on EDGAR →
8-K
Governance Other
confidence 85%
filed 2026-09-28
The filing discloses the Board's approval and implementation of a 1-for-12 reverse stock split, previously authorized by stockholders on November 6, 2025, effective September 30, 2026. This is a governance and capital structure event that affects all shareholders' holdings and is material to investors, though it does not fit the specific categories of exec_departure, exec_appointment, exec_compensation, or shareholder_vote_results (the vote already occurred). Reverse stock splits are governance decisions that materially affect share structure and are typically disclosed under Item 7.01 (Regulation FD Disclosure) as in this case.
View raw filing on EDGAR →
8-K
Operational Other
confidence 75%
filed 2026-09-28
Ainos entered into a Global Exclusive License Agreement with BioPhoenix on September 24, 2026, granting exclusive worldwide rights to develop and commercialize VELDONA® for Sjögren's Disease and Thrombocytopenia. The agreement includes an upfront fee of $600,000, potential additional payments up to ~$10 million, and 25% of net sublicensing revenue. This is a material strategic partnership that reduces Ainos' independent development burden while generating near-term and contingent revenue, but it is fundamentally an operational/strategic licensing transaction rather than a traditional M&A activity, debt issuance, or other specifically-named event type.
View raw filing on EDGAR →
6-K
Earnings release
confidence 95%
filed 2026-09-28
EX-99.1
This exhibit is a press release announcing unaudited financial results for the six months ended June 30, 2026. It discloses revenue of $6.2 million (140% increase), a $6.4 million net profit from operating units, and a 79% reduction in total net loss to $4 million. The document includes consolidated balance sheet, statements of operations, and cash flows for the interim period, along with financial highlights and strategic commentary from the CEO and CFO. This is a discrete earnings announcement, not a periodic financial report filing itself.
View raw filing on EDGAR →
8-K
Operational Other
confidence 75%
filed 2026-09-28
Item 7.01
Volato's Alignment Engine subsidiary has signed $1.2 billion in four-year, take-or-pay orders with a large AI customer for dedicated GPU infrastructure deployment. This represents a major commercial milestone and customer commitment for the company's AI infrastructure platform, including $133 million in contractual prepayments. While this is a significant operational and strategic business event—a material contract with a major customer—it does not fit neatly into the specific event categories (not M&A, not a debt issuance, not a capital raise, not a workforce action). The event is clearly operational/strategic in nature and material to investors assessing the company's growth trajectory and revenue visibility.
View raw filing on EDGAR →
8-K
Operational Other
confidence 72%
filed 2026-09-28
The filing discloses an operational update on Bitmine's cryptocurrency holdings and treasury strategy, announced via press release on September 28, 2026. The company reports reaching over 6 million ETH tokens (4.9% of total ETH supply), total holdings of $17.2 billion including crypto, cash, and marketable securities, and staking operations generating projected annualized revenues of $358 million. While this is primarily an operational/strategic disclosure about asset accumulation and business performance rather than a discrete event like M&A, earnings release, or executive change, the magnitude of holdings and revenue projections would be material to a reasonable investor assessing the registrant's financial position and strategic progress toward its stated "Alchemy of 5%" goal.
View raw filing on EDGAR →
8-K
M&A activity
confidence 95%
filed 2026-09-28
The filing discloses completion of a material disposition under Item 2.01. Greenpro Capital Corp. sold all equity interests in six subsidiaries (the "F&A Entities") to Ms. Chen Yanhong for HK$3,500,000 (approximately US$446,486) on September 28, 2026. The pro forma financial statements show the F&A Entities represented significant operations, contributing approximately $1.35 billion in service revenue in 2025 and $2.5 billion in 2024, and the transaction resulted in a $5.3 million reduction in additional paid-in capital. This is a material disposition of assets that would affect a reasonable investor's assessment of the company's operations and financial position.
View raw filing on EDGAR →
6-K
Dilutive issuance
confidence 95%
filed 2026-09-28
EX-99.1
Draganfly announces a registered direct offering of 1,869,159 common shares at US$5.35 per share for gross proceeds of approximately US$10 million. This is an unregistered equity issuance (though registered under Form F-10) that dilutes existing shareholders. The investment is from Unusual Machines (NYSE American: UMAC) and a leading U.S. Investment Fund, each investing $5M, representing a material capital raise that would affect investor assessment of ownership dilution and the company's strategic positioning.
View raw filing on EDGAR →
6-K
Delisting risk
confidence 98%
filed 2026-09-28
EX-99.1
The exhibit is a press release announcing that Nasdaq has issued a Staff Delisting Determination to delist Premium Catering's Class A Ordinary Shares from The Nasdaq Stock Market, citing concerns about third-party manipulation and insufficient liquidity under Nasdaq Listing Rule IM-5101-4. Although the Company intends to appeal and request a hearing before the Nasdaq Hearings Panel, the delisting determination itself represents a material delisting risk that would directly affect investor assessment of the registrant's continued listing status and market access.
View raw filing on EDGAR →
8-K
M&A activity
confidence 99%
filed 2026-09-28
The filing discloses entry into a definitive merger agreement on September 25, 2026, whereby Marygold will be acquired by funds managed by Madison Dearborn Partners for $2.00 per share in cash (a 100% premium to the prior closing price). The merger will result in Marygold becoming a privately held company with its stock delisted from NYSE American. This is a material acquisition and change of control transaction disclosed under Item 1.01.
View raw filing on EDGAR →
6-K
M&A activity
confidence 92%
filed 2026-09-28
EX-99.1
KNOREX announced it is pursuing a strategic carve-out of AscendX Media Technologies, its wholly owned publisher monetization subsidiary. Under the proposed structure, AscendX would be separated and independently capitalized with external investment, with KNOREX retaining a minority equity interest. This constitutes a material disposition or change of control of a significant business unit, fitting the definition of M&A activity (Items 1.01, 1.02, 2.01, 5.01). The transaction is expected to eliminate KNOREX's funding obligations for AscendX's future growth and allow the company to refocus on its core XPO platform, indicating materiality to investors' assessment of the registrant's capital allocation and strategic direction.
View raw filing on EDGAR →